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The number of cases and severity of disease associated 
with dengue infection in Sri Lanka has been increasing 
since 1989, when the fi rst epidemic of dengue hemorrhagic 
fever was recorded. We identifi ed a new dengue virus 1 
strain circulating in Sri Lanka that coincided with the 2009 
dengue epidemic.
Dengue virus (DENV) is a fl avivirus transmitted by Aedes spp. mosquitoes. There are 4 distinct 
DENV serotypes (DENV-1–4). Infection with a single 
serotype leads to long-term protective immunity against 
the homologous serotype but not against other serotypes 
(1). Globally, dengue is an emerging disease that causes 
an estimated 50–100 million infections, 500,000 dengue 
hemorrhagic fever (DHF) cases, and 22,000 deaths 
annually (2,3).
Epidemiologic and other studies indicate that risk 
factors for severe dengue include secondary infection with 
a heterologous serotype, the strain of infecting virus, and 
age and genetic background of the host. Studies are under 
way to further explore the role of these factors in severe 
disease (1,4).
In Sri Lanka, serologically confi rmed dengue was fi rst 
reported in 1962 (5), but although all 4 virus serotypes were 
present and there were cases of DHF, only since 1989 has 
DHF been considered endemic to Sri Lanka (5). Dengue 
was made a reportable disease in Sri Lanka in 1996, and the 
largest epidemic (35,008 reported cases, 170 cases/100,000 
population, and 346 deaths) occurred in 2009 (6). DHF 
epidemics in 1989 and 2002–2004 were associated with 
emergence of new clades of DENV-3 (7,8). We report a 
new DENV-1 genotype introduced to Sri Lanka before the 
2009 epidemic.
The Study
The study was approved by the Ethical Review 
Committee of the Faculty of Medicine, University of 
Colombo, Sri Lanka, and the Institutional Research 
Board of the International Vaccine Institute, Seoul, South 
Korea. Serum samples were obtained in 2009 and early 
2010 from patients as part of a Pediatric Dengue Vaccine 
Initiative (PDVI) fever surveillance study in Colombo, 
Sri Lanka. Samples were originally tested for dengue by 
reverse transcription PCR at Genetech Research Institute 
(Colombo, Sri Lanka). A random subset of dengue-
positive samples of all 4 serotypes was sent to the Program 
in Emerging Infectious Diseases Laboratory at Duke–
National University of Singapore Graduate Medical 
School, Singapore, for virus isolation and sequencing.
RNA was extracted from virus isolates, subjected to 
standard reverse transcription PCR to confi rm the presence 
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Figure. Phylogenetic tree of dengue virus 1 (DENV-1) serotype 
viruses from Sri Lanka (SL), 2009–2010, and other DENV-1 
viruses. The tree is based on a 498-bp (nt 2056–2554) fragment 
that encodes portions of the envelope protein and nonstructural 
protein 1. Phylogenetic analysis was conducted by using MEGA5 
(10). Percentages of replicate trees in which the associated taxa 
clustered in the bootstrap test (1,000 replicates) are shown next to 
the branches. Genotype I (Asia) includes SL isolates from 2009–
2010; genotype III (South Pacifi c) includes SL isolates from the 
early 1980s; genotype IV (Africa/Americas) includes SL isolates 
from the 1990s and early 2000s. Classifi cation and naming of 
DENV-1 genotypes are based on the report by Rico-Hesse (11). 
DV, dengue virus. Scale bar indicates nucleotide substitutions 
per site.
of dengue virus, and serotyped as described (7). Samples 
processed at Duke–National University of Singapore 
underwent whole-genome sequencing as described (9). 
Using DENV-1 isolates from Sri Lanka obtained from 
dengue cases in 1983, 1984, 1997, 2003, and 2004 (7) and 
representative DENV-1 sequences for the 4 genotypes, we 
constructed a phylogenetic tree by using MEGA5 software 
(10) (Figure; Table).
The 4 DENV serotypes found in Sri Lanka have been 
classifi ed into genotypes according to the nomenclature 
described by Rico-Hesse (11). The earliest isolates found 
in 1983 and 1984 belong to South Pacifi c genotype III. 
More recent isolates obtained during surveillance efforts 
during 1997–2004 belong to Africa/America genotype IV, 
indicating that at some point between the early 1980s and the 
mid 1990s, there was a DENV-1 genotype shift. Analysis of 
viruses isolated in 2009 indicated that another Asia genotype 
I of DENV-1 has been introduced into Sri Lanka (Figure) 
(7). This Asia genotype I virus appears to be responsible for 
the 2009 epidemic of dengue fever and DHF.
Conclusions
A feature of the epidemiology of dengue in Sri 
Lanka was the lack of DHF in the early 1980s and the 
increase in the number of severe dengue cases since 1989, 
more so after 2000. This fi nding was observed despite 
seroprevalence rates remaining largely the same over time 
as reported in a previous study (12) and in the current 
PDVI study (13).
Previous epidemics (1989 and 2002–2004) showed 
a correlation with evolution of DENV-3 genotype III in 
Sri Lanka, where emergence of new clades of DENV-3 
genotype 3 showed a correlation with large increases in the 
number of reported cases and the geographic range of the 
virus (7,8). A similar observation was reported for Puerto 
Rico by Bennett et al., who compared data for DEN2 
and DEN4 over 20 years and found that dominant clades 
were replaced by viral subpopulations existing within the 
population (14) and in the South Pacifi c region for DENV-
2, where a similar clade replacement occurred (15). These 
clade changes were accompanied by positive selection in 
the nonstructural protein 2A (NS-2A) gene for DENV-4 
and the envelope, premembrane, NS-2A, and NS-4A genes 
for DENV-2.
Our results indicate that introduction of a new DENV-
1 genotype coincided with the 2009 dengue epidemic in Sri 
Lanka. Studies are underway to determine if the proportion 
of DENV-1 cases in 2009 was greater than in previous 
years and to assess the role of this new DENV-1 genotype 
in the severe epidemic of 2009. Further studies are needed 
to determine if this new genotype has spread to other 
countries in the region.
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Table. Dengue virus type 1 strains used in analysis of new dengue virus genotype, Colombo, Sri Lanka 
Virus strain* Location Subtype Year isolated GenBank accession no. 
DV1_Aust_1983 Australia III 1983 AB074761 
DV1_West_Pacific_1974 Western Pacific III 1974 U88535 
DV1_Brazil_1990 Brazil IV 1990 AF226685 
DV1_China_1980 People’s Republic of China I 1980 AF350498 
DV1_Japan_43 Japan I 1943 AB074760 
DV1_Malaysia_72 Malaysia Sylvatic 1972 EF457905 
DV1_Seychelles_2004 Seychelles III 2004 DQ285561 
DV1_SL_1983a Sri Lanka III 1983 FJ225443 
DV1_SL_1984 Sri Lanka III 1984 FJ225444 
DV1_SL_1992a Sri Lanka IV 1992 FJ225445 
DV1_SL_1997a Sri Lanka IV 1997 FJ225446 
DV1_SL_2003a Sri Lanka IV 2003 FJ225447 
DV1_SL_2004a Sri Lanka IV 2004 FJ225448 
DV1_SL_2004b Sri Lanka IV 2004 FJ225449 
DV1_SL_2004c Sri Lanka IV 2004 FJ225450 
DV1_Thailand_64 Thailand II 1964 AF180818 
DV1_SL_2009a Sri Lanka I 2009 HQ891313 
DV1_SL_2009b Sri Lanka I 2009 HQ891314 
DV1_SL_2009c Sri Lanka I 2009 HQ891315 
DV1_SL_2009e Sri Lanka I 2009 JN054256 
DV1_SL_2010b Sri Lanka I 2010 JN054255 
*Strains are indicated as genotype_location_year. 
New Dengue Virus Type 1 Genotype in Sri Lanka
interests are the epidemiology, virology, surveillance, and control 
of dengue.
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